A case of carcinoma of the bladder in a patient treated for 20 years with Endoxan is reported. The role of this drug in the aetiology of an urothelial carcinoma was appeared to be demonstrated by the 35 published cases in the literature and should lead to a limitation of its prescription and to regulate urological surveillance of patients receiving the agent.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[urothelial cancers
4
cancers endoxan]
4
endoxan] case
4
case carcinoma
4
carcinoma bladder
4
bladder patient
4
patient treated
4
treated years
4
years endoxan
4
endoxan reported
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!